<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">369</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2025.6.3.99-105</article-id>
<title-group><article-title>Comparative Study of Hyperbaric Ropivacaine 0.75% and Hyperbaric Bupivacaine 0.5% for Spinal Anaesthesia</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Jain</surname><given-names>Rohit</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Goel</surname><given-names>Sharad</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Shailja</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<contrib contrib-type="author"><name><surname>Jain</surname><given-names>Ankit</given-names></name><xref ref-type="aff" rid="aff4"/></contrib>
<aff id="aff1"><label>1</label>Postgradutae Resident Anaesthesia, Department of Anesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India</aff>
<aff id="aff2"><label>2</label>Professor Anaesthesia, Department of Anesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India</aff>
<aff id="aff3"><label>3</label>Hod and Professor Anaesthesia, Department of Anesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India</aff>
<aff id="aff4"><label>4</label>Md Anaesthesia, Department of Anesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>01</day><month>08</month><year>2025</year></pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>99</fpage>
<lpage>105</lpage>
<history>
<date date-type="received"><day>23</day><month>06</month><year>2025</year></date>
<date date-type="accepted"><day>25</day><month>07</month><year>2025</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/369/comparative-study-of-hyperbaric-ropivacaine-0-75-and-hyperbaric-bupivacaine-0-5-for-spinal"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/369/download"/>
<abstract><p>Background: Local anesthetic selection for spinal anesthesia significantly influences block characteristics, safety profile, and patient outcomes. Ropivacaine, with its reduced cardiotoxicity and neurotoxicity compared to bupivacaine, has emerged as an attractive alternative for neuraxial anesthesia.
Objective: To compare the efficacy, safety, and block characteristics of hyperbaric ropivacaine 0.75% versus hyperbaric bupivacaine 0.5% in patients undergoing spinal anesthesia for lower abdominal and lower limb surgeries.
Methods: This prospective, randomized, double-blind study included 120 patients (ASA I-II) scheduled for elective surgery under spinal anesthesia. Patients were randomly allocated into two groups: Group R (n=60) received 15 mg of 0.75% hyperbaric ropivacaine, and Group B (n=60) received 15 mg of 0.5% hyperbaric bupivacaine. Primary outcomes included onset and duration of sensory and motor blockade. Secondary outcomes encompassed hemodynamic parameters, recovery characteristics, and adverse effects.
Results: Sensory block onset was faster in Group B (4.2±1.1 min) compared to Group R (5.8±1.4 min, p</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Spinal Anesthesia</kwd><kwd>Ropivacaine</kwd><kwd>Bupivacaine</kwd><kwd>Hyperbaric Solution</kwd><kwd>Local Anesthetics</kwd><kwd>Regional Anesthesia</kwd><kwd>Neuraxial Blockade</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321(7275):1493-7. International Journal of Medical and All Body Health Research www.allmedicaljournal.com</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Practice and Research Clinical Anaesthesiology. 2005;19(2):247-68.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Covino BG. Pharmacology of local anaesthetic agents. British Journal of Anaesthesia. 1986;58(7):701-16.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesthesia and Analgesia. 1985;64(7):715-30.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51(4):285-7.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>McClure JH. Ropivacaine. British Journal of Anaesthesia. 1996;76(2):300-7.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Markham A, Faulds D. Ropivacaine. A review of its pharmacology and therapeutic use in regional anaesthesia. Drugs. 1996;52(3):429-49.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesthesia and Analgesia. 1989;69(5):563-9.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Knudsen K, Beckman Suurküla M, Bloomfield S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. British Journal of Anaesthesia. 1997;78(5):507-14.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Groban L, Deal DD, Vernon JC, James RL, Butterworth J. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesthesia and Analgesia. 2001;92(1):37-43.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Zaric D, Nydahl PA, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: a double-blind study. Regional Anesthesia. 1996;21(1):14-25.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Gautier P, De Kock M, Huberty L, Demir T, Izydorczic M, Vanderick B. Comparison of the effects of intrathecal ropivacaine, levobupivacaine, and bupivacaine for Caesarean section. British Journal of Anaesthesia. 2003;</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Whiteside JB, Burke D, Wildsmith JA. Spinal anaesthesia with ropivacaine 5 mg/ml in glucose 50 mg/ml or fructose 50 mg/ml. British Journal of Anaesthesia. 2001;86(2):241-4.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Hocking G, Wildsmith JA. Intrathecal drug spread. British Journal of Anaesthesia. 2004;93(4):568-78.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Kallio H, Snäll EV, Tuomas CA, Rosenberg PH. Comparison of hyperbaric and plain ropivacaine 15 mg in spinal anaesthesia for lower limb surgery. British Journal of Anaesthesia. 2004;93(5):664-9.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Van Kleef JW, Veering BT, Burm AG. Spinal anesthesia with ropivacaine: a double-blind study on the efficacy and safety of 0.5% and 0.75% solutions in patients undergoing minor lower limb surgery. Anesthesia and Analgesia. 1994;78(6):1125-30.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Malinovsky JM, Charles F, Kick O, Lepage JY, Malinge M, Cozian A, et al. Intrathecal anesthesia: ropivacaine versus bupivacaine. Anesthesia and Analgesia. 2000;91(6):1457-60.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Wildsmith JA, Brown DT, Paul D, Johnson S. Structure-activity relationships in differential nerve block at high and low frequency stimulation. British Journal of Anaesthesia. 1989;63(4):444-52.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Luck JF, Fettes PD, Wildsmith JA. Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine. British Journal of Anaesthesia. 2008;101(5):705-10.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Fattorini F, Ricci Z, Rocco A, Romano R, Pascarella MA, Pinto G. Levobupivacaine versus racemic bupivacaine for spinal anaesthesia in orthopaedic major surgery. Minerva Anestesiologica. 2006;72(11):637-44.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Lee YY, Ngan Kee WD, Muchhal K, Chan CK. Randomized double blind comparison of ropivacaine and bupivacaine for caesarean section under spinal anaesthesia. British Journal of Anaesthesia. 2005;94(5):680-5.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Borghi B, Stagni F, Bugamelli S, Paini A, Gaspari G, Casati A, et al. Unilateral spinal block for outpatient knee arthroscopy: a dose-finding study. Journal of Clinical Anesthesia. 2003;15(5):351-6.</mixed-citation></ref>
</ref-list></back>
</article>